European Addiction Research
1998
Peter Schuster, Roselind Lieb, Christina Maria Lamertz et al.
96 citations
This report presents findings of a community survey of 3,021 adolescents and young adults aged 14–24 years in Munich, Germany, carried out to determine the prevalence of use and abuse of and dependence on ecstasy, amphetamines and hallucinogens. The response rate was 71%. <b>Results:</b> (1) In 1995, 4% of the male and 2.3% of the female respondents aged 14–24 reported the use of ecstasy....
Pediatrics
October 1, 1997
Richard H. Schwartz, Norman S. Miller
155 citations
The drug 3,4 methylenedioxymethamphetamine (MDMA), also known as "ecstasy," is a "designer" drug that is becoming popular with American adolescents at dance halls known as "raves" and on college campuses. An analogue of amphetamine, MDMA shares properties with both amphetamine and hallucinogenic drugs. Now available in many US cities, MDMA has an undeserved reputation for safety and a long...
Neuropsychopharmacology
September 1997
H K Kramer, Jose C Poblete, Efrain C. Azmitia
This report further characterizes the intermediate metabolic effects of the psychotropic amphetamine derivative, 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"), on the activity of second messenger-dependent kinases. Previous work has demonstrated that two injections of MDMA (20 mg/kg) elicits a prolonged translocation of the calcium and phospholipid-dependent enzyme, protein kinase C...
Brain Research
September 1, 1997
Hema Mann, Bruce Ladenheim, Hiroshi Hirata et al.
50 citations
The toxic effects of methamphetamine (METH) (2.5, 5.0 and 10.0 mg/kg) and methylenedioxymethamphetamine (MDMA) (5.0, 10.0 and 20.0 mg/kg) on dopaminergic systems were assessed in the striatum and of the nucleus accumbens in mdr1a wild-type and knockout mice. METH caused significant dose-dependent decreases of dopamine (DA) and DA transporters (DAT) in the striatum and the nucleus accumbens...
Emergency Medicine Journal
September 1, 1997
A. Mallick, Andrew Bodenham
59 citations
A young male survived hyperpyrexia (42.9 degrees C) following MDMA ("Ecstasy") ingestion. He developed convulsions, rhabdomyolysis, metabolic acidosis, and respiratory failure. This was successfully managed by assisted ventilation, aggressive fluid therapy, and the early administration of dantrolene, in addition to cooling measures. This is the first report of a survivor with such a severe...
Human Psychopharmacology: Clinical and Experimental
September 1, 1997
A. C. Parrott, Marta Stuart
24 citations
Twenty-one recreational polydrug users (age range: 17–34 years), were recruited into the study using the 'snowball' technique (Solowij et al., 1992). All had used MDMA (3,4-methylenedioxymethamphetamine, or 'Ecstasy'), LSD (lysergic acid diethylamide), and amphetamine, on different occasions. They completed modified Profile of Mood States Questionnaires, to indicate their typical feeling states...
Pharmacology, Biochemistry, and Behavior
August 1997
L E Baker, M M Taylor
The phenylisopropylamine derivatives 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) have been compared to both psychostimulants and hallucinogens in drug discrimination investigations. The stereoisomers of these compounds, in particular those of MDA, appear to produce differential effects. Previous studies have demonstrated that animals trained to discriminate...
British Journal of Pharmacology
July 1, 1997
María Isabel Colado, Esther O’shea, R Granados et al.
175 citations
Administration of 3,4‐methylenedioxymethamphetamine (MDMA or ‘ecstasy’) to several species results in a long lasting neurotoxic degeneration of 5‐hydroxytryptaminergic neurones in several regions of the brain. We have now investigated whether this degeneration is likely to be the result of free radical‐induced damage. Free radical formation can be assessed by measuring the formation of 2,3‐ and...
Addiction
July 1, 1997
Valerie H. Curran, Ross A. Travill
283 citations
Abstract Aims. Recreational use of ± 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) is widespread. The present study aimed to examine both the acute and residual effects of this drug on users' mood and cognitive Junction. Design and participants. A parallel group design was used to compare 12 participants who reported having taken MDMA with 12 participants who reported having consumed only...
British Journal of Pharmacology
June 1, 1997
María Isabel Colado, Esther O’shea, R Granados et al.
176 citations
It is well established that 3,4‐methylenedioxymethamphetamine (MDMA or ‘ecstasy’) is neurotoxic and produces long term degeneration of cerebral 5‐hydroxytryptamine (5‐HT) nerve terminals in many species. Since MDMA is used extensively as a recreational drug by young people, it is being ingested by many women of child bearing age. We have therefore examined the effect of administering high doses...